Diagnostic bone scanning in oncology

被引:65
作者
Krasnow, AZ
Hellman, RS
Timins, ME
Collier, BD
Anderson, T
Isitman, AT
机构
[1] MED COLL WISCONSIN, DEPT INTERNAL MED, MILWAUKEE, WI 53226 USA
[2] ZABLOCKI VET ADM MED CTR, MILWAUKEE, WI 53295 USA
关键词
D O I
10.1016/S0001-2998(97)80043-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Over the last several decades bone scanning has been used extensively in the evaluation of oncology patients to detect bone involvement. It can provide information about disease location, prognosis, and the effect of therapy. Bone scanning offers the advantages of whole body evaluation and the detection of lesions earlier than other techniques. However, as newer diagnostic tools become available, indications for bone scanning must be revised and the results combined with these other tests in order to provide optimum patient care. Advances in instrumentation and the subsequent improvement in image quality have allowed nuclear medicine physicians to provide more accurate bone scan interpretations. By optimizing image acquisition, it is often possible to determine lesion characteristics, which are more likely to represent malignancy. Knowledge of disease pathophysiology and other specific properties of the patient's primary tumor, along with subsequent correlation of scan abnormalities to patient history, physical examination, previous studies, and other radiological examinations, is essential for determining lesion significance. The differential diagnosis of a scan abnormality should also include consideration of both false normal and abnormal causes. The final interpretation should be clearly communicated to the clinician with appropriate recommendations for further evaluation. Only through careful attention to the patient, the clinician, and appropriate study acquisition parameters will bone scanning maintain its place in the evaluation of oncology patients. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:107 / 141
页数:35
相关论文
共 158 条
[1]   SKELETAL SCINTIGRAPHY IN CARCINOMA OF THE BREAST - A 10 YEAR RETROSPECTIVE STUDY OF 389 PATIENTS [J].
AHMED, A ;
GLYNNEJONES, R ;
ELL, PJ .
NUCLEAR MEDICINE COMMUNICATIONS, 1990, 11 (06) :421-426
[2]   DETECTION OF VERTEBRAL METASTASES - COMPARISON BETWEEN MR IMAGING AND BONE-SCINTIGRAPHY [J].
ALGRA, PR ;
BLOEM, JL ;
TISSING, H ;
FALKE, THM ;
ARNDT, JW ;
VERBOOM, LJ .
RADIOGRAPHICS, 1991, 11 (02) :219-232
[3]   DO METASTASES IN VERTEBRAE BEGIN IN THE BODY OR THE PEDICLES - IMAGING STUDY IN 45 PATIENTS [J].
ALGRA, PR ;
HEIMANS, JJ ;
VALK, J ;
NAUTA, JJ ;
LACHNIET, M ;
VANKOOTEN, B .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 158 (06) :1275-1279
[4]   COMPARISON OF PHOSPHATASE ISOENZYMES PAP AND PSA WITH BONE-SCAN IN PATIENTS WITH PROSTATE CARCINOMA [J].
AMICO, S ;
LIEHN, JC ;
DESOIZE, B ;
LARBRE, H ;
DELTOUR, G ;
VALEYRE, J .
CLINICAL NUCLEAR MEDICINE, 1991, 16 (09) :643-648
[5]   EARLY MR DEMONSTRATION OF SPINAL METASTASES IN PATIENTS WITH NORMAL RADIOGRAPHS AND CT AND RADIONUCLIDE BONE SCANS [J].
AVRAHAMI, E ;
TADMOR, R ;
DALLY, O ;
HADAR, H .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1989, 13 (04) :598-602
[6]  
Bal C. S., 1996, Journal of Nuclear Medicine, V37, p137P
[7]   CLINICAL UTILITY OF BONE SPECT SCINTIGRAPHY IN RENAL METASTASES FROM PRIMARY OSTEOSARCOMA [J].
BALINGIT, AG ;
RUDD, S ;
WILLIAMS, S .
CLINICAL NUCLEAR MEDICINE, 1994, 19 (12) :1098-1101
[8]  
BARICHELLO M, 1995, EUR UROL, V27, P295
[9]  
BARSHALOM R, 1995, J NUCL MED, V36, P446
[10]   THE ETIOLOGY OF SOLITARY HOT-SPOTS IN THE RIBS ON PLANAR BONE SCANS [J].
BAXTER, AD ;
COAKLEY, FV ;
FINLAY, DB ;
WEST, C .
NUCLEAR MEDICINE COMMUNICATIONS, 1995, 16 (10) :834-837